Katz-Feigenbaum D, Braun L, Wolinsky H
Circ Res. 1981 Sep;49(3):733-41. doi: 10.1161/01.res.49.3.733.
Thyroid hormones influence circulating low density lipoprotein (LDL) levels in humans; they could have an effect on LDL catabolism. Male rats were thyroidectomized (H); half were treated for 7 days with 2 micrograms triiodothyronine/100 g body weight (T) and both groups were compared to controls (C). Aorta, liver, and kidney were assayed for cellular marker enzymes, including lysosomal acid cholesteryl esterase (ACE). Specific activities of ACE (mU/mg DNA; mean +/- SD) were: Aorta, C, 0.19 +/- 0.01; H, 0.16 +/- 0.01; T, 0.21 +/- 0.01; Liver: C, 15.55 +/- 1.49; H, 9.16 +/- 1.54; T, 15.43 +/- 2.28; Kidney: C, 1.70 +/- 0.23; H, 1.04 +/- 0.13; T, 2.08 +/- 0.35. Half lives for injected unmodified 125I-labeled human LDL were 11.5 +/- 0.7 hour in C, 16.2 +/- 3.1 in H, and 12.9 +/- 0.9 in T groups. Fractional catabolic rates (FCR) of LDL in %/hr were 6.5 +/- 0.6 in C; 4.8 +/- 0.5 in H, and 6.0 +/- 0.3 in T. Reductively methylated 125I-labeled human LDL had half-lives of 14.9 +/0 1.4 hour in C and 15.1 +/- 1.6 hour in H and the FCR of this modified LDL was 5.3 +/- 0.5 %/hr in C and 5.2 +/- 0.7 %/hr in H groups. Thus, thyroidectomy results in marked decreases in ACE specific activity of liver and kidney and a marked decrease in FCR and prolonged half-life of non-modified LDL (all P less than 0.05). On the other hand, methylated LDL showed a similarly reduced FCR and prolonged half-life in control and thyroidectomized rats (P less than 0.05). This suggests a major effect of thyroid deficiency on receptor-mediated uptake of LDL in vivo and demonstrates the influence of hormonal status on dynamic clearance and catabolism of LDL.
甲状腺激素会影响人体循环中的低密度脂蛋白(LDL)水平;它们可能对LDL分解代谢产生影响。将雄性大鼠进行甲状腺切除(H组);其中一半用2微克三碘甲状腺原氨酸/100克体重治疗7天(T组),并将两组与对照组(C组)进行比较。对主动脉、肝脏和肾脏进行细胞标记酶检测,包括溶酶体酸性胆固醇酯酶(ACE)。ACE的比活性(mU/mg DNA;平均值±标准差)如下:主动脉,C组为0.19±0.01;H组为0.16±0.01;T组为0.21±0.01;肝脏:C组为15.55±1.49;H组为9.16±1.54;T组为15.43±2.28;肾脏:C组为1.70±0.23;H组为1.04±0.13;T组为2.08±0.35。注射未修饰的125I标记的人LDL的半衰期在C组为11.5±0.7小时,在H组为16.2±3.1小时,在T组为12.9±0.9小时。LDL的分解代谢率(FCR)以%/小时计,C组为6.5±0.6;H组为4.8±0.5,T组为6.0±0.3。还原甲基化的125I标记的人LDL在C组的半衰期为14.9±1.4小时,在H组为15.1±1.6小时,这种修饰LDL在C组的FCR为5.3±0.5 %/小时,在H组为5.2±0.7 %/小时。因此,甲状腺切除导致肝脏和肾脏的ACE比活性显著降低,FCR显著降低,未修饰LDL的半衰期延长(所有P值均小于0.05)。另一方面,甲基化LDL在对照组和甲状腺切除大鼠中显示出类似的FCR降低和半衰期延长(P值小于0.05)。这表明甲状腺功能减退对体内受体介导的LDL摄取有重大影响,并证明了激素状态对LDL动态清除和分解代谢的影响。